Status: Enrolling
Investigator: Mahwash Kassi
Study Coordinator:
Phone:
To evaluate the efficacy of eplontersen compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more information, please visit https://www.cardio-ttransform.com. ... Read more >
